Results 71 to 80 of about 817,244 (208)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer

open access: yesFrontiers in Oncology, 2020
Background: Lobectomy with mediastinal lymph node dissection has always been recognized as the standardized treatment for early-stage non-small-cell lung cancer.
Bo Hao   +6 more
doaj   +1 more source

Anatomic thoracoscopic segmentectomy for early-stage lung cancer [PDF]

open access: yesJournal of Visualized Surgery, 2017
Over the past 20 years, there have been significant advancements in thoracoscopic surgical techniques as well as in lung cancer screening protocols, which have identified greater numbers of smaller lung tumors (
Chi-Fu Jeffrey, Yang   +4 more
openaire   +2 more sources

The role of robotic segmentectomy for non-small cell lung cancer

open access: yes, 2020
Segmentectomy may be applied to all segments; superior segmentectomies (lower lobe superior segments for both lungs), lingulectomies (two segments forming lingulas of upper left lobe) and basal segmentectomies (segments other than superior segment for ...
Yucel Akkas, Anil Gokce*, Bulent Kocer
core   +1 more source

Decoding Malignant Lung Ground Glass Opacities: A Radiologic–Pathologic Study From Pure to Semi‐Solid Lesions

open access: yesThoracic Cancer, Volume 17, Issue 17, September 2026.
In our study, among 135 completely resected pure or partially solid malignant GGOs, the presence of a feeding arterial vessel is an independent predictor to consolidation. Pathological variables are reported as early as this stage and LVI+ mGGOs present a significant lower disease‐free survival, regardless of their consolidation.
Alessandro Bonis   +15 more
wiley   +1 more source

Intraoperative Rapid On‐Site Evaluation (ROSE) vs. Frozen Section in Lung Surgery: A Prospective Study on Diagnostic Speed and Accuracy

open access: yesThoracic Cancer, Volume 17, Issue 17, September 2026.
Intraoperative frozen‐section assessment for pulmonary lesions prolongs surgery. In 75 patients with 81 samples, we compared rapid on‐site evaluation (ROSE) with frozen section. ROSE greatly reduced diagnostic time with reliable diagnostic accuracy. ROSE represents a valuable auxiliary tool for rapid intraoperative lung‐tumor diagnosis.
Honghai Ma   +8 more
wiley   +1 more source

Anatomical Segmentectomy with a Hybrid VATS Approach in a Patient with Intralobar Pulmonary Sequestration after Severe Pneumonia: A Case Report

open access: yesEuropean Journal of Pediatric Surgery Reports, 2017
Anatomical segmentectomy is an advantageous procedure because it spares healthy lung that has potential to show compensatory growth after lung resection and decreases the risk of air leak and residual resection, which becomes a problem in wedge resection.
Soichi Shibuya   +2 more
doaj   +1 more source

Uniportal video-assisted thoracic lung segmentectomy with near infrared/indocyanine green intersegmental plane identification

open access: yes, 2018
In the era of lung cancer screening and early detection of lung lesions, pulmonary segmentectomy has gained wide acceptance between thoracic community reducing the need of lobectomy for diagnostic purpose and treatment in case of centrally located benign,
Meacci, Elisa   +11 more
core   +1 more source

Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB–IIIA Non‐Small‐Cell Lung Cancer: Phase 2 neoSCORE Trial

open access: yesCancer Science, Volume 117, Issue 9, Page 2509-2520, September 2026.
Kaplan–Meier survival curves comparing two‐cycle versus three‐cycle neoadjuvant sintilimab plus chemotherapy. (A) Disease‐free survival (DFS). (B) Overall survival (OS). CI, confidence interval; HR, hazard ratio; NR, not reached. ABSTRACT The optimal number of neoadjuvant chemoimmunotherapy cycles for resectable non‐small cell lung cancer (NSCLC ...
Miner Shao   +13 more
wiley   +1 more source

Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non‐Small Cell Lung Cancer

open access: yesCancer Science, Volume 117, Issue 9, Page 2535-2542, September 2026.
The flow of this trial and the treatment schedule of adjuvant chemotherapy with nedaplatin plus docetaxel for completely resected non‐small cell lung cancer (NSCLC) (A). The primary endpoint of this study was tolerability, assessed by the completion rate of the planned four chemotherapy cycles. As a result, it was 74.3%, exceeding that reported for the
Koji Teramoto   +9 more
wiley   +1 more source

Guideline concordance of stage IIIA non‐small‐cell lung cancer treatment in the Australian setting

open access: yesInternal Medicine Journal, Volume 56, Issue 9, Page 1593-1599, September 2026.
Abstract Background Stage IIIA non‐small‐cell lung cancer (NSCLC) is a life‐limiting disease, and the level of adherence to evidence‐based treatment guidelines in the Australian setting is unclear. Aim To assess the level of adherence to stage IIIA NSCLC treatment guidelines prior to the advent of immunotherapy and highlight factors that may contribute
Georgia Ross   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy